INTERNATIONAL PATENT: TONGJI HOSPITAL, TONGJI MEDICAL COLLEGE, HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY, 华中科技大学同济医学院附属同济医院 FILES APPLICATION FOR "USE OF NARINGENIN IN PREPARING DRUG FOR TREATING UTERINE LEIOMYOMA OR UTERINE SARCOMA"

GENEVA, Nov. 3 -- TONGJI HOSPITAL, TONGJI MEDICAL COLLEGE, HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (No.1095, Jiefang Avenue, Qiaokou DistrictWuhan, Hubei 430030), 华中科技大学同济医学院附属同济医院 (中国湖北省武汉市硚口区解放大道1095号) filed a patent application (PCT/CN2025/090585) for "USE OF NARINGENIN IN PREPARING DRUG FOR TREATING UTERINE LEIOMYOMA OR UTERINE SARCOMA" on Apr 23, 2025. With publication no. WO/2025/223439, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was su...